← All companies

LIPO

Lipella Pharmaceuticals Inc.

LIPO OTC Pharmaceutical Preparations EDGAR ↗

$0.03

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$152K

Revenue (TTM)

$470K

Net income (TTM)

-$5.33M

EPS (TTM)

$-2.43

P/E ratio

—

Dividend yield

—

Free cash flow

-$3.97M

Cash

$1.86M

Total assets

$2.35M

Gross margin

—

52-week range

$0.02 – $0.70

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Bankruptcy or receivership Jul 15, 2026 8-K Bankruptcy or receivership Mar 31, 2026 8-K Director or officer change Feb 4, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Oct 21, 2025 8-K Director or officer change Oct 9, 2025 8-K Regulation FD disclosure; Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Regulation FD disclosure; Other events Jun 25, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Jun 20, 2025 8-K Other events Jun 16, 2025 8-K Delisting notice or listing-rule failure May 16, 2025 8-K Regulation FD disclosure; Other events May 15, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Other events Apr 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws Apr 9, 2025 8-K Entered a material agreement Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 18, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 11, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 3, 2025 8-K Entered a material agreement Feb 24, 2025 8-K Regulation FD disclosure; Other events Feb 11, 2025 8-K Delisting notice or listing-rule failure Jan 13, 2025 8-K Entered a material agreement; Unregistered sale of equity Jan 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Dec 30, 2024 8-K Other events Dec 27, 2024 8-K Other events Dec 20, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 10, 2024 8-K Other events Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Modified rights of security holders; Amended charter or bylaws Nov 7, 2024 8-K Other events Nov 1, 2024 8-K Delisting notice or listing-rule failure Oct 18, 2024 8-K Shareholder vote results Sep 11, 2024 8-K Delisting notice or listing-rule failure Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Other events Aug 6, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 1, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024